Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Tectonic Therapeutic, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
TECX
Nasdaq
2836
tectonictx.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Tectonic Therapeutic, Inc.
Tectonic Therapeutic (TECX): LifeSci Capital Reiterates Buy Rating
- Dec 10th, 2025 12:13 pm
Tectonic Therapeutic to Participate in December Investor Conferences
- Dec 1st, 2025 6:00 am
Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans
- Nov 22nd, 2025 7:14 am
Tectonic Therapeutic Announces Third Quarter 2025 Financial Results and Recent Business Highlights
- Nov 6th, 2025 2:01 pm
Tectonic Therapeutic Announces Positive Topline Data from Phase 1b Part B Clinical Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFrEF
- Oct 29th, 2025 2:01 pm
Bullish Tectonic Therapeutic Insiders Loaded Up On US$61.2m Of Stock
- Oct 12th, 2025 7:26 am
Tectonic Therapeutic to Participate in September Investor Conferences
- Aug 28th, 2025 7:00 am
Tectonic Therapeutic Announces Second Quarter 2025 Financial Results and Recent Business Highlights
- Aug 7th, 2025 2:01 pm
Tectonic Therapeutic Joins Russell 3000® Index
- Jun 30th, 2025 6:00 am
Raymond James Resumes Coverage of Tectonic Therapeutic (TECX) With an Outperform Rating
- Jun 24th, 2025 3:42 pm
We Think Tectonic Therapeutic (NASDAQ:TECX) Can Afford To Drive Business Growth
- Jun 15th, 2025 6:49 am
Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure 2025
- May 17th, 2025 8:40 am
Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights
- May 8th, 2025 2:01 pm
Tectonic Therapeutic To Present on May 15th, 2025 at the Bank of America Securities Health Care Conference
- May 7th, 2025 6:00 am
Insider Stock Buying Reaches US$62.6m On Tectonic Therapeutic
- May 5th, 2025 6:04 am
TipRanks’ ‘Perfect 10’ Picks: 2 Top-Scoring Stocks Earning Wall Street’s Seal of Approval
- May 1st, 2025 3:59 am
Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025
- Apr 15th, 2025 6:00 am
Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
- Mar 20th, 2025 2:01 pm
Tectonic Therapeutic to Participate in March Investor Conferences
- Feb 20th, 2025 6:00 am
Tectonic Announces $185 Million Private Placement
- Feb 3rd, 2025 4:30 am
Scroll